User
Favorite list
As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is committed to providing our customers around the world with the highest quality products. In addition to direct selling in more than 20 countries in North America, Europe and Asia/Pacific, Miltenyi Biotec also provides support for our customers through an extensive distributor network covering dozens of additional countries.
BERGISCH GLADBACH, April 20, 2017 – MACS® GMP T Cell TransAct™ is a ready-to-use reagent for efficient in vitro activation and expansion of human T cells. Also available in research grade.
Cell activation is a prerequisite for the successful genetic engineering of T cells. MACS GMP T Cell TransAct from Miltenyi Biotec – with its unique features – enables in vitro stimulation, activation, and expansion of human T cells from hematological cell populations (e.g. PBMCs). Polyclonal T cell expansion can be used in numerous applications including cellular therapy or whenever T cells are activated to improve gene modification.
Benefits of MACS GMP T Cell TransAct are:
Innovative format: A colloidal polymeric nanomatrix conjugated to humanized, recombinant CD3 and CD28 agonists.
Ease of use: Effective activation for a large range of cell densities.
Convenience: Excess reagent is simply washed off.
Safety: Biodegradable, ready to use and compatible with the automated, functionally-closed CliniMACS Prodigy® System.
For further information see miltenyibiotec.com/transact
Miltenyi Biotec Media Contact
Dr. Anja Kohmann
Publication free of charge – Specimen copy requested.
Copyright © 2020 Miltenyi Biotec and/or its affiliates. All rights reserved.
